Last checked at 31 Jul 2020 16:31
Renalytix AI plc
(the "Company")
Total Voting Rights
For the purposes of DTR5.6.1R of the Transparency Directive, the Company notifies the market of the following:
As of 31 July 2020, the Company's issued and fully paid share capital consists of 72,029,634 ordinary shares with a nominal value of £0.0025 each ("Ordinary Shares"), with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. The total number of voting rights in the Company is therefore 72,029,634.
The above figure of 72,029,634 should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.
For further information, please contact:
Renalytix AI plc | www.renalytixai.com | |
James McCullough, CEO | Via Walbrook PR | |
Stifel (Nominated Adviser) | Tel: 020 7710 7600 | |
Alex Price / Nicholas Moore | ||
Walbrook PR Limited | Tel: 020 7933 8780 or renalytix@walbrookpr.com | |
Paul McManus / Lianne Cawthorne | Mob: 07980 541 893 / 07584 391 303 | |